Natixis’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $125M | Buy |
2,068,064
+522,535
| +34% | +$30.5M | 0.45% | 25 |
|
|
2025
Q4 | $83.4M | Buy |
1,545,529
+857,973
| +125% | +$41.3M | 0.3% | 45 |
|
|
2025
Q3 | $31M | Buy |
687,556
+329,164
| +92% | +$15.4M | 0.14% | 129 |
|
|
2025
Q2 | $16.6M | Sell |
358,392
-51,702
| -13% | -$2.54M | 0.07% | 170 |
|
|
2025
Q1 | $25.1M | Sell |
410,094
-834,762
| -67% | -$48.7M | 0.14% | 119 |
|
|
2024
Q4 | $70.4M | Sell |
1,244,856
-108,957
| -8% | -$6.09M | 0.43% | 35 |
|
|
2024
Q3 | $70M | Sell |
1,353,813
-240,118
| -15% | -$11.3M | 0.39% | 48 |
|
|
2024
Q2 | $66.2M | Buy |
+1,593,931
| New | +$71.3M | 0.38% | 48 |
|
|
2024
Q1 | – | Sell |
-158,441
| Closed | -$8.13M | – | 1024 |
|
|
2023
Q4 | $8.13M | Buy |
+158,441
| New | +$8.32M | 0.06% | 243 |
|
|
2023
Q3 | – | Sell |
-1,298,735
| Closed | -$83.1M | – | 994 |
|
|
2023
Q2 | $83.1M | Buy |
1,298,735
+854,960
| +193% | +$57.3M | 0.67% | 23 |
|
|
2023
Q1 | $30.8M | Sell |
443,775
-940,060
| -68% | -$66.3M | 0.28% | 81 |
|
|
2022
Q4 | $99.6M | Sell |
1,383,835
-4,601,506
| -77% | -$347M | 0.56% | 44 |
|
|
2022
Q3 | $430M | Buy |
5,985,341
+307,361
| +5% | +$22.3M | 2.01% | 5 |
|
|
2022
Q2 | $436M | Buy |
5,677,980
+4,885,184
| +616% | +$372M | 1.58% | 6 |
|
|
2022
Q1 | $57.9M | Sell |
792,796
-21,560
| -3% | -$1.45M | 0.2% | 108 |
|
|
2021
Q4 | $50.8M | Buy |
814,356
+390,789
| +92% | +$22.9M | 0.17% | 103 |
|
|
2021
Q3 | $25.1M | Sell |
423,567
-473,723
| -53% | -$31.2M | 0.09% | 199 |
|
|
2021
Q2 | $59.5M | Sell |
897,290
-209,038
| -19% | -$13.6M | 0.26% | 84 |
|
|
2021
Q1 | $69.8M | Sell |
1,106,328
-176,290
| -14% | -$11M | 0.23% | 94 |
|
|
2020
Q4 | $79.6M | Buy |
+1,282,618
| New | +$78.9M | 0.29% | 73 |
|
|
2020
Q3 | – | Sell |
-1,052,049
| Closed | -$61.9M | – | 771 |
|
|
2020
Q2 | $61.9M | Sell |
1,052,049
-440,693
| -30% | -$26.4M | 0.48% | 41 |
|
|
2020
Q1 | $83.2M | Buy |
1,492,742
+687,686
| +85% | +$42M | 0.65% | 37 |
|
|
2019
Q4 | $51.3M | Buy |
805,056
+625,735
| +349% | +$35.8M | 0.32% | 88 |
|
|
2019
Q3 | $9.09M | Sell |
179,321
-290,217
| -62% | -$13.6M | 0.06% | 272 |
|
|
2019
Q2 | $21.3M | Buy |
469,538
+223,551
| +91% | +$10.4M | 0.16% | 128 |
|
|
2019
Q1 | $11.8M | Sell |
245,987
-364,237
| -60% | -$18.1M | 0.07% | 249 |
|
|
2018
Q4 | $31.7M | Buy |
610,224
+98,333
| +19% | +$5.28M | 0.26% | 101 |
|
|
2018
Q3 | $31.8M | Sell |
511,891
-163,969
| -24% | -$9.73M | 0.18% | 128 |
|
|
2018
Q2 | $37.1M | Sell |
675,860
-16,021
| -2% | -$865K | 0.2% | 116 |
|
|
2018
Q1 | $43.5M | Buy |
691,881
+74,903
| +12% | +$4.82M | 0.27% | 88 |
|
|
2017
Q4 | $37.8M | Buy |
616,978
+392,997
| +175% | +$24.6M | 0.29% | 91 |
|
|
2017
Q3 | $14.3M | Sell |
223,981
-39,324
| -15% | -$2.3M | 0.13% | 155 |
|
|
2017
Q2 | $14.7M | Buy |
+263,305
| New | +$14.3M | 0.17% | 137 |
|
|
2017
Q1 | – | Sell |
-301,236
| Closed | -$17.6M | – | 942 |
|
|
2016
Q4 | $17.6M | Buy |
301,236
+43,655
| +17% | +$2.39M | 0.18% | 142 |
|
|
2016
Q3 | $13.9M | Buy |
257,581
+146,252
| +131% | +$9.39M | 0.16% | 119 |
|
|
2016
Q2 | $8.19M | Sell |
111,329
-150,375
| -57% | -$10.6M | 0.15% | 133 |
|
|
2016
Q1 | $16.7M | Buy |
+261,704
| New | +$16.5M | 0.28% | 68 |
|
|
2015
Q4 | – | Sell |
-70,374
| Closed | -$4.17M | – | 315 |
|
|
2015
Q3 | $4.17M | Buy |
+70,374
| New | +$4.46M | 0.09% | 90 |
|
|
2014
Q4 | – | Sell |
-531,417
| Closed | -$27.2M | – | 388 |
|
|
2014
Q3 | $27.2M | Sell |
531,417
-595,273
| -53% | -$29.7M | 0.42% | 42 |
|
|
2014
Q2 | $54.7M | Buy |
1,126,690
+131,145
| +13% | +$6.46M | 0.66% | 36 |
|
|
2014
Q1 | $51.7M | Sell |
995,545
-171,952
| -15% | -$9.15M | 0.67% | 36 |
|
|
2013
Q4 | $62.1M | Sell |
1,167,497
-627,427
| -35% | -$32M | 0.53% | 39 |
|
|
2013
Q3 | $83.1M | Sell |
1,794,924
-502,010
| -22% | -$22M | 0.89% | 19 |
|
|
2013
Q2 | $103M | Buy |
+2,296,934
| New | +$99.7M | 1.47% | 10 |
|
Other funds holding BMY
VCM
VPM
Natixis's BMY Position: Q1 2026 in Review
Natixis increased its Bristol-Myers Squibb (BMY) stake by 34% in Q1 2026, buying an estimated $30.5M and bringing the position to 2,068,064 shares worth $125M. The position accounts for 0.45% of the portfolio, ranked #25.
Natixis first reported a position in BMY in Q2 2013 and has held it in 44 quarters since. The position peaked at $436M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Natixis held 2,068,064 shares of Bristol-Myers Squibb worth $125M as of Q1 2026.
- Natixis bought 522,535 Bristol-Myers Squibb shares in Q1 2026, an estimated $30.5M.
- Bristol-Myers Squibb made up 0.45% of Natixis's portfolio in Q1 2026, its #25 holding.
- Natixis first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 44 quarters since.
- Natixis's Bristol-Myers Squibb position peaked at $436M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.